GHK-Cu Monitoring Schedule: Labs & Exams You Need At a glance Drug / GHK-Cu is a tripeptide-copper(II) complex first isolated from human plasma albumin Route / subcutaneous injection or topical (compounded under FDA section 503A) Baseline labs / serum copper, ceruloplasmin, CBC with differential, CMP including liver enzymes Recheck interval / 4 weeks after initiation, then every 8 to 12 weeks Normal serum copper / 70 to 140 g/dL (11 to 22 mol/L) Ceruloplasmin target / 20 to 35 mg/dL Liver enzymes / ALT and AST should remain below 2x upper limit of normal 24-hour urine copper / ordered if serum copper exceeds 155 g/dL on two consecutive draws Skin exam / baseline and every 12 weeks for subcutaneous injection sites Discontinuation trigger / serum copper above 200 g/dL or ceruloplasmin below 15 mg/dL How GHK-Cu Works: Mechanism Before Monitoring GHK-Cu is glycyl-L-histidyl-L-lysine bound to a single copper(II) ion
While meningococcal interactions on the surface of epithelial and endothelial cells have been intensively investigated, leading to the identification of key determinants of virulence of this bacterium, relatively little is known about the crossing of the nasopharyngeal epithelial barrier (NEB), the BBB, and BCSFB by the meningococcus
10.1016/j.peptides.2024.171200 26 MunshiM
Biochem Biophys Res Commun (2008) 370:5848
So from that side of it, from a repair side, from the inflammatory part, youre going to see immediately
